Northwestern Medicine scientists have developed a novel synthetic biomolecular condensate that can degrade intracellular ...

In a collaborative effort, co-corresponding author Tanja Mittag, PhD, and co-first author Wade Borcherds, PhD, St. Jude Department of Structural Biology, interrogated the interaction networks within ...

For decades, cancer research has focused on the dysregulation of various cellular pathways, including transcription, chromatin structure, proliferative signaling, RNA processing, and genomic integrity ...

Biologists discovered that a scaffolding protein called TCOF1 is responsible for the formation of a biomolecular condensate called the fibrillar center, which forms within the cell nucleolus. Inside ...

A research group led by Professor Hiroaki SUZUKI and Takeshi HAYAKAWA from the Faculty of Science and Engineering at Chuo University, graduate student Zhitai HUANG, graduate students Kanji KANEKO (at ...

Researchers from Dewpoint Therapeutics published a paper “Modulating biomolecular condensates: a novel approach to drug discovery” in Nature Reviews Drug Discovery that examines the potential of ...

Biomolecular condensates are membraneless hubs of condensed proteins and nucleic acids within cells, which researchers are realizing are tied to an increasing number of cellular processes and diseases ...

Round led by Northpond Ventures, with participation from Taiho Ventures, Bristol Myers Squibb, Lifeforce Capital and Magnetic Ventures Investment accelerates the Company’s Condensomics™ platform, a ...

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration ...